rational
lung
transplant
insult
allograft
gener
result
one
four
histopatholog
pattern
injuri
acut
reject
lymphocyt
bronchiol
organ
pneumonia
diffus
alveolar
damag
dad
hypothes
dad
sever
form
acut
lung
injuri
would
lead
highest
risk
chronic
lung
allograft
dysfunct
clad
type
immun
respons
would
mediat
process
object
determin
whether
dad
associ
clad
explor
potenti
role
biolog
method
transbronchi
biopsi
lung
transplant
recipi
review
associ
four
injuri
pattern
subsequ
outcom
evalu
use
proport
hazard
model
timedepend
covari
bronchoalveolar
lavag
bal
concentr
ligand
compar
allograft
injuri
pattern
healthi
biopsi
use
linear
mixedeffect
model
effect
chemokin
alter
clad
risk
assess
use
cox
model
serial
bal
measur
timedepend
covari
measur
main
result
biopsi
recipi
episod
dad
episod
dad
associ
increas
risk
clad
hazard
ratio
confid
interv
death
hazard
ratio
confid
interv
mark
elev
bal
ligand
concentr
dad
furthermor
prolong
elev
chemokin
serial
bal
fluid
measur
predict
develop
clad
conclus
dad
associ
mark
increas
risk
clad
death
lung
transplant
associ
may
mediat
part
aberr
type
immun
respons
involv
antibodymedi
reject
air
pollut
gastroesophag
reflux
sever
respiratori
infect
colon
despit
numer
insult
limit
number
histopatholog
pattern
acut
allograft
injuri
foremost
prototyp
pattern
ar
consist
perivascular
mononuclear
infiltr
may
extend
interstitium
alveolar
space
lymphocyt
bronchiol
lb
airwaycent
pattern
character
peribronchiolar
mononuclear
cell
infiltr
organ
pneumonia
op
character
excess
prolifer
granul
tissu
within
alveolar
duct
alveoli
diffus
alveolar
damag
dad
initi
exud
phase
epitheli
endotheli
breakdown
alveolar
protein
leak
edema
format
macrophag
activ
neutrophil
recruit
prolif
phase
character
type
ii
pneumocyt
fibroblast
prolifer
extracellular
matrix
deposit
mark
interstiti
thicken
dad
consid
sever
form
acut
lung
allograft
injuri
caus
number
insult
includ
pgd
infect
sepsi
drug
toxin
sever
ar
dad
commonli
observ
allograft
particularli
immedi
postop
period
pgd
although
sever
studi
evalu
dad
caus
pgd
pauciti
inform
pathogenesi
clinic
consequ
dad
occur
periop
period
histopatholog
four
allograft
injuri
pattern
common
theme
involv
extravas
infiltr
leukocyt
area
injuri
elrcxc
chemokin
ligand
signal
share
g
proteincoupl
receptor
chemokin
induc
interferong
act
potent
chemoattract
mononuclear
cell
eg
activ
cell
natur
killer
cell
group
previous
demonstr
role
biolog
pathogenesi
allograft
reject
dysfunct
anim
studi
allograft
injuri
pattern
ar
lb
op
dad
determin
interact
host
recipi
allograft
donor
insult
thu
hypothes
pattern
sever
allograft
injuri
would
stronger
determin
clad
variou
insult
caus
specif
sever
form
lung
injuri
dad
associ
highest
risk
clad
hypothes
associ
mediat
part
aberr
type
immun
respons
involv
biolog
axi
irb
approv
perform
retrospect
review
ltr
univers
california
lo
angel
januari
decemb
patient
receiv
surveil
bronchoscopi
bronchoalveolar
lavag
bal
transbronchi
biopsi
tbbx
month
posttranspl
episod
clinic
deterior
approxim
tbbx
obtain
bronchoscopi
biopsi
interpret
one
three
pulmonari
pathologist
accord
intern
multidisciplinari
consensu
statement
idiopath
interstiti
pneumonia
dad
op
intern
societi
heart
lung
transplant
criteria
ar
lb
lb
grade
present
absent
march
thereaft
grade
accord
revis
intern
societi
heart
lung
transplant
criteria
ungrad
exclud
event
immedi
postop
period
eg
pgd
tbbx
collect
less
day
transplant
exclud
episod
dad
occur
day
attribut
persist
pgd
also
exclud
immunosuppress
antimicrobi
prophylaxi
administ
accord
univers
california
lo
angel
lung
transplant
protocol
previous
describ
gener
episod
ar
treat
three
dose
solumedrol
mg
intraven
follow
prednison
mgkg
daili
week
taper
mg
per
week
previou
dose
manag
dad
discret
transplant
pulmonologist
treatment
regimen
includ
highdos
solumedrol
intraven
immunoglobulin
plasmapheresi
basiliximab
thymoglobulin
spirometri
perform
everi
week
first
month
posttranspl
everi
week
thereaft
clad
defin
sustain
drop
least
fev
averag
two
best
posttranspl
fev
measur
clad
classifi
ra
bo
base
spirometri
chest
comput
tomographi
ct
per
definit
sato
cowork
ra
defin
dfvc
dfev
greater
chest
ct
show
groundglass
opacif
interstiti
reticul
interlobular
septal
thicken
recipi
clad
fulfil
criteria
ra
consid
bo
phenotyp
allograft
mortal
defin
death
retranspl
biopsi
data
collect
surgic
patholog
report
code
presenc
absenc
dad
ar
grade
greater
lb
op
biopsi
describ
ungrad
consid
miss
valu
subset
patient
consent
collect
bal
fluid
balf
research
purpos
time
bronchoscopi
three
aliquot
isoton
salin
instil
subsegment
bronchu
lingula
right
middl
lobe
area
interest
pool
centrifug
supernat
collect
store
c
chemokin
concentr
measur
use
luminex
technolog
standard
elisa
bead
assay
biorad
life
scienc
research
hercul
ca
bead
assay
millipor
billerica
duoset
kit
r
system
minneapoli
mn
accord
manufactur
instruct
lower
limit
detect
pgml
respect
balf
sampl
unconcentr
immunohistochemistri
ihc
perform
formalinfix
paraffinembed
tissu
local
chemokin
ligand
previous
describ
detail
provid
onlin
supplement
cox
proport
hazard
model
timedepend
cumul
count
dad
ar
lb
op
construct
take
effect
multipl
sampl
per
patient
frequenc
recurr
injuri
pattern
injuri
pattern
cumul
count
increas
zero
one
first
episod
injuri
one
two
second
episod
forth
addit
four
injuri
pattern
univari
model
includ
plausibl
demograph
variabl
associ
poor
clinic
outcom
age
greater
male
sex
singl
lung
transplant
pretranspl
diagnosi
time
transplant
time
transplant
divid
tertil
refer
group
final
model
determin
use
backward
select
method
p
use
covari
univari
model
subgroup
analys
among
bilater
ltr
perform
evalu
associ
injuri
pattern
phenotyp
clad
ra
bo
use
causespecif
proport
hazard
model
timedepend
cumul
count
dad
ar
lb
op
logtransform
chemokin
concentr
compar
healthi
patholog
biopsi
use
linear
mixedeffect
model
account
repeat
measur
time
transplant
vs
includ
covari
explor
whether
prolong
alter
chemokin
predict
clad
serial
ligand
concentr
includ
timedepend
variabl
cox
model
clad
analys
perform
sa
sa
institut
inc
cari
nc
definit
abbrevi
aat
antitrypsin
atg
thymoglobulin
bo
bronchiol
obliteran
syndrom
cf
cystic
fibrosi
copd
chronic
obstruct
pulmonari
diseas
dad
diffus
alveolar
damag
ild
interstiti
lung
diseas
ipf
idiopath
pulmonari
fibrosi
htn
hypertens
lam
lymphangioleiomyomatosi
plch
pulmonari
langerhan
cell
histiocytosi
total
bronchoscopi
tbbx
transplant
recipi
period
studi
three
hundr
fortythre
tbbx
exclud
analysi
collect
first
day
posttranspl
n
persist
pgd
n
ungrad
sampl
n
remain
biopsi
recipi
avail
analysi
figur
biopsi
perivascular
ar
pattern
recipi
grade
follow
grade
grade
grade
grade
biopsi
lb
recipi
biopsi
op
recipi
biopsi
dad
recipi
one
hundr
seventyseven
tbbx
concurr
injuri
pattern
common
cooccurr
ar
lb
n
lb
op
n
dad
occur
lb
n
op
n
ar
n
seven
hundr
ninetyon
biopsi
recipi
evid
histopatholog
classifi
healthi
biopsi
preval
histopatholog
injuri
pattern
vari
time
transplant
figur
gener
frequenc
per
biopsi
ar
lb
op
greatest
first
day
posttranspl
observ
frequenc
respect
contrast
frequenc
dad
exclud
case
caus
pgd
start
near
first
day
increas
first
year
tabl
list
patient
characterist
whether
ever
episod
dad
proport
hazard
model
clad
construct
timedepend
variabl
four
injuri
pattern
plausibl
demograph
variabl
associ
poor
clinic
outcom
tabl
univari
model
episod
dad
associ
highest
risk
clad
hazard
ratio
hr
confid
interv
ci
follow
ar
hr
ci
op
hr
ci
lb
hr
ci
none
demograph
variabl
associ
clad
multivari
model
dad
remain
strongest
predictor
clad
hr
ci
follow
singl
lung
transplant
hr
ci
ar
hr
ci
lb
hr
ci
tabl
injuri
pattern
hr
repres
increas
risk
singl
episod
injuri
evalu
associ
injuri
pattern
phenotyp
clad
bo
ra
subset
analys
among
doubl
lung
transplant
dad
episod
among
doubl
ltr
develop
clad
twentysix
ltr
dad
clad
ct
scan
avail
review
met
criteria
ra
base
combin
spirometr
ct
definit
wherea
remain
consid
bo
multivari
model
dad
hr
ci
ar
hr
ci
associ
develop
ra
tabl
ar
injuri
pattern
associ
develop
bo
hr
ci
unabl
estim
risk
bo
dad
limit
sampl
size
given
larg
hr
observ
dad
kaplanmei
curv
freedom
clad
construct
stratifi
whether
recipi
ever
episod
dad
incid
clad
recipi
least
one
episod
dad
versu
recipi
episod
dad
p
figur
recipi
develop
clad
dad
median
time
dad
clad
onset
day
allograft
mortal
defin
death
n
retranspl
n
tabl
multivari
model
dad
hr
ci
clad
hr
ci
op
hr
ci
age
greater
hr
ci
remain
signific
tabl
kaplanmei
curv
allograft
mortal
construct
stratifi
whether
recipi
ever
episod
dad
incid
allograft
mortal
recipi
least
one
episod
dad
versu
recipi
episod
dad
p
figur
recipi
allograft
mortal
dad
median
time
dad
allograft
mortal
day
attempt
determin
specif
caus
dad
use
microbiolog
cultur
tbbx
cultur
stain
organ
radiograph
studi
clinic
note
treat
physician
case
n
discern
caus
dad
etiolog
dad
could
identifi
common
viral
infect
cytomegaloviru
n
parainfluenza
n
bocaviru
n
one
case
mix
human
metapneumoviruscoronaviru
n
etiolog
dad
includ
nonvir
pulmonari
infect
n
aspir
n
sever
ar
n
recurr
sarcoid
n
dad
ar
lb
predict
clad
develop
multivari
cox
model
test
hypothesi
type
immun
respons
involv
biolog
involv
associ
dad
ar
lb
clad
develop
balf
ligand
concentr
compar
biopsi
without
patholog
find
healthi
biopsi
dad
ar
lb
total
assay
balf
sampl
recipi
healthi
sampl
recipi
dad
sampl
recipi
ar
sampl
recipi
lb
sampl
recipi
median
balf
concentr
higher
dad
fourfold
higher
ar
threefold
higher
lb
compar
healthi
biopsi
tabl
similarli
balf
concentr
increas
dad
ar
lb
increas
less
pronounc
balf
concentr
mildli
elev
dad
ar
lb
given
increas
balf
concentr
ligand
dad
ar
lb
explor
whether
prolong
elev
chemokin
would
predict
clad
cox
model
clad
construct
serial
bal
measur
ligand
timedepend
covari
three
ligand
concentr
associ
increas
risk
clad
tenfold
increas
associ
hr
ci
ci
ci
respect
tabl
use
ihc
lung
biopsi
tissu
determin
cellular
sourc
chemokin
share
receptor
dad
n
express
airway
bronchial
epitheli
cell
subepitheli
interstiti
infiltr
mononuclear
cell
alveolar
macrophag
contrast
predomin
express
vascular
endotheli
cell
express
bronchial
epitheli
cell
infiltr
mononuclear
cell
alveolar
macrophag
figur
contrast
prior
studi
clad
focus
specif
insult
allograft
eg
pgd
gastroesophag
reflux
infect
studi
focus
common
pathway
allograft
injuri
ar
lb
op
dad
determin
interact
host
allograft
insult
evalu
tbbx
ltr
found
dad
sever
form
lung
injuri
associ
highest
risk
subsequ
clad
hr
ci
death
hr
ci
hypothes
associ
dad
clad
would
mediat
part
aberr
type
immun
respons
involv
biolog
use
balf
analysi
found
mark
elev
definit
abbrevi
allograft
mortal
death
retranspl
ar
acut
reject
cf
cystic
fibrosi
ci
confid
interv
clad
chronic
lung
allograft
dysfunct
copd
chronic
obstruct
pulmonari
diseas
dad
diffus
alveolar
damag
hr
hazard
ratio
ipf
idiopath
pulmonari
fibrosi
lb
lymphocyt
bronchiol
op
organ
pneumonia
ph
pulmonari
hypertens
tx
transplant
time
tx
first
tertil
second
tertil
refer
group
multivari
model
includ
variabl
list
dad
op
clad
age
greater
p
z
p
x
p
balf
ligand
concentr
dad
furthermor
chronic
elev
chemokin
determin
serial
balf
measur
predict
develop
clad
taken
togeth
find
support
potenti
role
biolog
axi
continuum
dad
clad
previou
studi
repeatedli
implic
ar
major
risk
factor
develop
clad
sever
studi
also
report
associ
lb
clad
consist
studi
found
ar
lb
associ
clad
univari
multivari
model
acut
lung
allograft
injuri
pattern
dad
associ
highest
risk
clad
univari
multivari
analys
remark
episod
dad
incid
clad
compar
without
suggest
dad
omin
sign
futur
graft
dysfunct
recent
studi
sato
cowork
evalu
develop
clad
bo
ra
dad
among
bilater
ltr
use
pft
lung
volum
measur
found
earli
dad
mo
posttranspl
increas
risk
bo
hr
ci
wherea
late
dad
mo
posttranspl
increas
risk
ra
hr
ci
routin
obtain
lung
volum
measur
center
use
surrog
spirometr
ct
definit
ra
bilater
ltr
advoc
sato
cowork
concord
result
sato
cowork
found
nonpgdassoci
episod
dad
posttranspl
strongli
associ
ra
hr
ci
ar
associ
ra
hr
ci
bo
hr
ci
subset
analysi
limit
small
sampl
size
support
strong
associ
dad
develop
clad
particularli
ra
phenotyp
found
dad
associ
profound
increas
risk
death
even
control
clad
recipi
singl
episod
dad
allograft
mortal
compar
without
dad
result
conflict
studi
sato
cowork
found
associ
lateonset
dad
overal
mortal
studi
requir
reconcil
discrep
similar
previou
studi
case
dad
discern
caus
mani
case
recipi
treat
antimicrobi
bronchoscopi
lower
yield
infecti
diagnosi
addit
sensit
polymeras
chain
reactionbas
respiratori
viru
panel
becam
routin
institut
etiolog
could
determin
infect
viral
nonvir
still
common
caus
dad
follow
aspir
sever
ar
hypothes
base
group
prior
anim
data
associ
dad
clad
would
mediat
part
aberr
type
immun
respons
involv
biolog
rodent
model
ar
clad
demonstr
chemokin
recruit
mononuclear
cell
share
receptor
lead
allograft
fibroplasia
inhibit
ligand
result
profound
attenu
allograft
reject
dysfunct
smaller
clinic
studi
group
other
demonstr
increas
balf
concentr
ligand
ar
clad
current
studi
evalu
balf
sampl
recipi
found
elev
ar
lb
expect
even
greater
elev
chemokin
dad
parallel
risk
subsequ
clad
develop
evalu
involv
interact
pathogenesi
clad
explor
whether
chronic
elev
balf
ligand
concentr
increas
risk
clad
use
cox
model
serial
measur
ligand
timedepend
covari
found
three
ligand
predict
clad
develop
character
chemokin
express
pattern
ihc
studi
conduct
biopsi
dad
express
primarili
bronchial
epitheli
cell
infiltr
mononuclear
cell
alveolar
macrophag
contrast
predomin
express
vascular
endotheli
cell
express
bronchial
epitheli
cell
infiltr
mononuclear
cell
alveolar
macrophag
collect
find
support
coordin
effort
chemokin
variou
compart
within
lung
act
recruit
express
mononuclear
cell
blood
stream
lung
express
mononuclear
cell
move
site
lung
allograft
injuri
along
andor
chemokin
gradient
compartment
chemokin
may
explain
appar
contradict
less
pronounc
increas
balf
higher
effect
estim
clad
although
less
detect
alveolar
compart
balf
augment
vasculatur
may
import
effect
mononuclear
cell
traffick
clad
develop
major
limit
studi
potenti
confound
inher
retrospect
studi
exampl
patient
experienc
clinic
deterior
may
frequent
biopsi
lead
higher
incid
histopatholog
find
furthermor
patient
found
allograft
injuri
may
receiv
treatment
taken
account
institut
patient
routin
receiv
augment
immunosuppress
ar
dad
addit
data
lb
grade
factor
may
weaken
associ
lb
clad
subtyp
bo
ra
lastli
studi
design
account
lung
allograft
injuri
captur
transbronchi
biopsi
undoubtedli
episod
allograft
injuri
miss
infrequ
tbbx
sampl
believ
major
strength
studi
identif
potenti
mechan
explain
associ
dad
ar
lb
clad
develop
specif
role
biolog
propag
damag
inflammatori
milieu
allograft
injuri
pattern
like
repres
deleteri
cycl
cell
damag
type
immun
respons
mediat
part
recruit
injuri
mononuclear
cell
allograft
caus
cell
damag
eventu
fibroprolifer
studi
evalu
serial
balf
histopatholog
ltr
knowledg
largest
studi
evalu
chemokin
express
pattern
lung
allograft
injuri
conclus
result
suggest
histopatholog
find
dad
omin
harbing
develop
clad
death
find
studi
repres
first
step
elucid
mechan
link
dad
clad
futur
studi
investig
involv
chemokin
pathway
cytokin
pathway
eg
allograft
injuri
pharmacolog
disrupt
interact
strategi
decreas
clad
develop
among
ltr
author
disclosur
avail
text
articl
wwwatsjournalsorg
